News
Article
FDA and NIH Win Award for IP Licensing of Meningitis Vaccine
Author(s):
Partnership is awarded for licensing of low-cost vaccine for the treatment of bacterial meningitis.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Videos
Related Content
